U.S. pharmaceutical company Moderna vaccine application for approval as the third case in Japan
The third domestic application for approval of the new coronavirus vaccine was submitted for the vaccine of the American pharmaceutical company Moderna.
The Japanese government has signed a contract to supply 50 million doses of the new coronavirus vaccine developed by Moderna for 25 million people by September.
Takeda Pharmaceutical Company Limited, which handles distribution, applied for approval from the Ministry of Health, Labor and Welfare for use in Japan on the 5th.
Moderna`s vaccine has already been inoculated in the United States, Canada, etc., and the data of the clinical trial in the United States was submitted to the Ministry of Health, Labor and Welfare on the 5th.
In Japan, clinical trials have been conducted on 200 Japanese men and women over the age of 20 since January, and the data is expected to be submitted to the Ministry of Health, Labor and Welfare by May.
Regarding the vaccine for the new corona virus, of the three Western companies that have signed a contract to receive the supply from the Japanese government, the vaccine of the American pharmaceutical giant Pfizer was approved in February, and the vaccine of the British pharmaceutical giant AstraZeneca was also approved in February. The application has been submitted and is being reviewed
Todaii Japanese is a website for learning and reading Japanese news integrating various features such as dictionary, practice, testing, ...
https://todaiinews.com
todai.easylife@gmail.com
(+84) 865 924 966
315 Truong Chinh, Khuong Mai, Thanh Xuan, Hanoi
Home
Video
JLPT Test
Dictionary
Lesson
Topic
